The latest study on Dengue Vaccine Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Dengue Vaccine Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Dengue Vaccine and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
U.S NIH
Vabiotech
Dengue Vaccine Market Analysis By Type Segment:
CYD-TDV
DENVax or TAK-003
TetraVax-DV
TDENV PIV
V180
DNA vaccines
Dengue Vaccine Market Analysis By Application Segment:
Government Institutions
Hospitals
NGOs
Dengue Vaccine Market Analysis By Regions (Countries):
The Dengue Vaccine Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Dengue Vaccine Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Dengue Vaccine Market:
Dengue Vaccine market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Dengue Vaccine Market status and future forecast.
To present the key Dengue Vaccine Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Study Coverage
1.1 Dengue Vaccine Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type
1.4.2 CYD-TDV
1.4.3 DENVax or TAK-003
1.4.4 TetraVax-DV
1.4.5 TDENV PIV
1.4.6 V180
1.4.7 DNA vaccines
1.5 Market by Application
1.5.1 Global Dengue Vaccine Market Size Growth Rate by Application
1.5.2 Government Institutions
1.5.3 Hospitals
1.5.4 NGOs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dengue Vaccine Market Size
2.1.1 Global Dengue Vaccine Revenue 2016-2027
2.1.2 Global Dengue Vaccine Sales 2016-2027
2.2 Dengue Vaccine Growth Rate by Regions
2.2.1 Global Dengue Vaccine Sales by Regions
2.2.2 Global Dengue Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Dengue Vaccine Sales by Manufacturers
3.1.1 Dengue Vaccine Sales by Manufacturers
3.1.2 Dengue Vaccine Sales Market Share by Manufacturers
3.2 Dengue Vaccine Revenue by Manufacturers
3.2.1 Dengue Vaccine Revenue by Manufacturers (2020)
3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2020)
3.3 Dengue Vaccine Price by Manufacturers
3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dengue Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Dengue Vaccine Sales by Type
4.2 Global Dengue Vaccine Revenue by Type
4.3 Dengue Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Dengue Vaccine Breakdown Data by Application
6 North America
6.1 North America Dengue Vaccine by Country
6.1.1 North America Dengue Vaccine Sales by Country
6.1.2 North America Dengue Vaccine Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dengue Vaccine by Type
6.3 North America Dengue Vaccine by Application
7 Europe
7.1 Europe Dengue Vaccine by Country
7.1.1 Europe Dengue Vaccine Sales by Country
7.1.2 Europe Dengue Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dengue Vaccine by Type
7.3 Europe Dengue Vaccine by Application
8 Asia Pacific
8.1 Asia Pacific Dengue Vaccine by Region
8.1.1 Asia Pacific Dengue Vaccine Sales by Region
8.1.2 Asia Pacific Dengue Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Dengue Vaccine by Type
8.3 Asia Pacific Dengue Vaccine by Application
9 Central & South America
9.1 Central & South America Dengue Vaccine by Country
9.1.1 Central & South America Dengue Vaccine Sales by Country
9.1.2 Central & South America Dengue Vaccine Revenue by Country
9.1.3 Brazil
9.2 Central & South America Dengue Vaccine by Type
9.3 Central & South America Dengue Vaccine by Application
10 Middle East and Africa
10.1 Middle East and Africa Dengue Vaccine by Country
10.1.1 Middle East and Africa Dengue Vaccine Sales by Country
10.1.2 Middle East and Africa Dengue Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Dengue Vaccine by Type
10.3 Middle East and Africa Dengue Vaccine by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Company Details
11.2.2 Company Business Overview
11.2.3 Merck Sharp & Dohme Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered
11.2.5 Merck Sharp & Dohme Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.3.4 Sanofi Dengue Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Takeda Pharmaceuticals Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered
11.4.5 Takeda Pharmaceuticals Recent Development
11.5 GeneOne Life Sciences
11.5.1 GeneOne Life Sciences Company Details
11.5.2 Company Business Overview
11.5.3 GeneOne Life Sciences Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered
11.5.5 GeneOne Life Sciences Recent Development
11.6 Medigen Biologics
11.6.1 Medigen Biologics Company Details
11.6.2 Company Business Overview
11.6.3 Medigen Biologics Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.6.4 Medigen Biologics Dengue Vaccine Products Offered
11.6.5 Medigen Biologics Recent Development
11.7 Panacea Biotec
11.7.1 Panacea Biotec Company Details
11.7.2 Company Business Overview
11.7.3 Panacea Biotec Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.7.4 Panacea Biotec Dengue Vaccine Products Offered
11.7.5 Panacea Biotec Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Sun Pharmaceutical Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered
11.8.5 Sun Pharmaceutical Recent Development
11.9 U.S NIH
11.9.1 U.S NIH Company Details
11.9.2 Company Business Overview
11.9.3 U.S NIH Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.9.4 U.S NIH Dengue Vaccine Products Offered
11.9.5 U.S NIH Recent Development
11.10 Vabiotech
11.10.1 Vabiotech Company Details
11.10.2 Company Business Overview
11.10.3 Vabiotech Dengue Vaccine Sales, Revenue and Gross Margin (2020)
11.10.4 Vabiotech Dengue Vaccine Products Offered
11.10.5 Vabiotech Recent Development
12 Future Forecast
12.1 Dengue Vaccine Market Forecast by Regions
12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2021-2027
12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2021-2027
12.2 Dengue Vaccine Market Forecast by Type
12.2.1 Global Dengue Vaccine Sales Forecast by Type 2021-2027
12.2.2 Global Dengue Vaccine Revenue Forecast by Type 2021-2027
12.3 Dengue Vaccine Market Forecast by Application
12.4 North America Dengue Vaccine Forecast
12.5 Europe Dengue Vaccine Forecast
12.6 Asia Pacific Dengue Vaccine Forecast
12.7 Central & South America Dengue Vaccine Forecast
12.8 Middle East and Africa Dengue Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dengue Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Dengue Vaccine Product Picture
Table Dengue Vaccine Market Segments
Table Key Manufacturers Dengue Vaccine Covered
Table Global Dengue Vaccine Market Size Growth Rate by Type 2021-2027 (K Doses) & (Million US$)
Figure Global Dengue Vaccine Sales Market Share by Type in 2020 & 2027
Figure CYD-TDV Product Picture
Table Major Manufacturers of CYD-TDV
Figure DENVax or TAK-003 Product Picture
Table Major Manufacturers of DENVax or TAK-003
Figure TetraVax-DV Product Picture
Table Major Manufacturers of TetraVax-DV
Figure TDENV PIV Product Picture
Table Major Manufacturers of TDENV PIV
Figure V180 Product Picture
Table Major Manufacturers of V180
Figure DNA vaccines Product Picture
Table Major Manufacturers of DNA vaccines
Table Global Dengue Vaccine Market Size Growth Rate by Application 2021-2027 (K Doses)
Figure Global Dengue Vaccine 4900 Sales Market Share by Application in 2020
Figure Government Institutions
Figure Hospitals
Figure NGOs
Figure Dengue Vaccine Report Years Considered
Figure Global Dengue Vaccine Market Size 2016-2027 (Million US$)
Figure Global Dengue Vaccine Sales 2016-2027 (K Doses)
Table Global Dengue Vaccine Market Size by Regions 2016-2020 (K Doses) & (Million US$)
Table Global Dengue Vaccine Sales by Regions 2016-2020 (K Doses)
Table Global Dengue Vaccine Sales Market Share by Regions 2016-2020
Figure Global Dengue Vaccine Sales Market Share by Regions 2016-2020
Figure 2020 Global Dengue Vaccine Sales Market Share by Regions
Table Global Dengue Vaccine Revenue by Regions 2016-2020 (Million US$)
Table Global Dengue Vaccine Revenue Market Share by Regions 2016-2020
Figure Global Dengue Vaccine Revenue Market Share by Regions 2016-2020
Figure 2020 Global Dengue Vaccine Revenue Market Share by Regions
Table Global Dengue Vaccine Sales by Manufacturers (2020) (K Doses)
Table Global Dengue Vaccine Sales Share by Manufacturers (2020)
Figure Global Dengue Vaccine Sales Share by Manufacturers in 2020
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Dengue Vaccine Revenue by Manufacturers (2020) (Million USD)
Table Dengue Vaccine Revenue Share by Manufacturers (2020)
Figure Dengue Vaccine Value Share by Manufacturers in 2020
Table Key Manufacturers Dengue Vaccine Price (2016-2020) (USD/Dose)
Table Dengue Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Dengue Vaccine Product Type
Table Date of International Manufacturers Enter into Dengue Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Dengue Vaccine Sales by Type (2016-2020) (K Doses)
Table Global Dengue Vaccine Sales Share by Type (2016-2020)
Figure Global Dengue Vaccine Sales Market Share by Type (2016-2020)
Figure Global Dengue Vaccine Sales Market Share by Type in 2020
Table Global Dengue Vaccine Revenue by Type (2016-2020) (Million US$)
Table Global Dengue Vaccine Revenue Share by Type (2016-2020)
Figure Global Dengue Vaccine Revenue Market Share by Type (2016-2020)
Figure Global Dengue Vaccine Revenue Market Share by Type in 2020
Table Dengue Vaccine Price by Type 2016-2020 (USD/Dose)
Table Global Dengue Vaccine Sales by Application (2016-2020) (K Doses)
Table Global Dengue Vaccine Sales Share by Application (2016-2020)
Figure Global Sales Dengue Vaccine Market Share by Application (2016-2020)
Figure Global Sales Dengue Vaccine Market Share by Application in 2020
Figure North America Dengue Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure North America Dengue Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table North America Dengue Vaccine Sales by Country (2016-2020) (K Doses)
Table North America Dengue Vaccine Sales Market Share by Country (2016-2020)
Figure 2020 North America Dengue Vaccine Sales Market Share by Country
Table North America Dengue Vaccine Revenue by Country (2016-2020) (Million US$)
Table North America Dengue Vaccine Revenue Market Share by Country (2016-2020)
Figure 2020 North America Dengue Vaccine Revenue Market Share by Country
Figure United States Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure United States Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Canada Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Canada Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Mexico Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Mexico Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table North America Dengue Vaccine Sales by Type (2016-2020) (K Doses)
Table North America Dengue Vaccine Sales Market Share by Type (2016-2020)
Figure 2020 North America Dengue Vaccine Market Share by Type
Table North America Dengue Vaccine Sales by Application (2016-2020) (K Doses)
Table North America Dengue Vaccine Sales Market Share by Application (2016-2020)
Figure 2020 North America Dengue Vaccine Market Share by Application
Figure Europe Dengue Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Europe Dengue Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Europe Dengue Vaccine Sales by Country (2016-2020) (K Doses)
Table Europe Dengue Vaccine Sales Market Share by Country (2016-2020)
Figure 2020 Europe Dengue Vaccine Sales Market Share by Country
Table Europe Dengue Vaccine Revenue by Country (2016-2020) (Million US$)
Table Europe Dengue Vaccine Revenue Market Share by Country (2016-2020)
Figure 2020 Europe Dengue Vaccine Revenue Market Share by Country
Figure Germany Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Germany Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure France Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure France Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure UK Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure UK Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Italy Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Italy Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Russia Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Russia Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Europe Dengue Vaccine Sales by Type (2016-2020) (K Doses)
Table Europe Dengue Vaccine Sales Market Share by Type (2016-2020)
Figure 2020 Europe Dengue Vaccine Market Share by Type
Table Europe Dengue Vaccine Sales by Application (2016-2020) (K Doses)
Table Europe Dengue Vaccine Sales Market Share by Application (2016-2020)
Figure 2020 Europe Dengue Vaccine Market Share by Application
Figure Asia Pacific Dengue Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Asia Pacific Dengue Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Asia Pacific Dengue Vaccine Sales by Region (2016-2020) (K Doses)
Table Asia Pacific Dengue Vaccine Sales Market Share by Region (2016-2020)
Figure 2020 Asia Pacific Dengue Vaccine Sales Market Share by Region
Table Asia Pacific Dengue Vaccine Revenue by Region (2016-2020) (Million US$)
Table Asia Pacific Dengue Vaccine Revenue Market Share by Region (2016-2020)
Figure 2020 Asia Pacific Dengue Vaccine Revenue Market Share by Country
Figure China Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure China Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Japan Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Japan Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure South Korea Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure South Korea Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure India Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure India Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Australia Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Australia Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Indonesia Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Indonesia Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Thailand Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Thailand Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Malaysia Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Malaysia Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Philippines Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Philippines Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Vietnam Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Vietnam Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Asia Pacific Dengue Vaccine Sales by Type (2016-2020) (K Doses)
Table Asia Pacific Dengue Vaccine Sales Market Share by Type (2016-2020)
Figure 2020 Asia Pacific Dengue Vaccine Market Share by Type
Table Asia Pacific Dengue Vaccine Sales by Application (2016-2020) (K Doses)
Table Asia Pacific Dengue Vaccine Sales Market Share by Application (2016-2020)
Figure 2020 Asia Pacific Dengue Vaccine Market Share by Application
Figure Central & South America Dengue Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Central & South America Dengue Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Central & South America Dengue Vaccine Sales by Country (2016-2020) (K Doses)
Table Central & South America Dengue Vaccine Sales Market Share by Country (2016-2020)
Figure 2020 Central & South America Dengue Vaccine Sales Market Share by Country
Table Central & South America Dengue Vaccine Revenue by Country (2016-2020) (Million US$)
Table Central & South America Dengue Vaccine Revenue Market Share by Country (2016-2020)
Figure 2020 Central & South America Dengue Vaccine Revenue Market Share by Country
Figure Brazil Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Brazil Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Central & South America Dengue Vaccine Sales by Type (2016-2020) (K Doses)
Table Central & South America Dengue Vaccine Sales Market Share by Type (2016-2020)
Figure 2020 Central & South America Dengue Vaccine Market Share by Type
Table Central & South America Dengue Vaccine Sales by Application (2016-2020) (K Doses)
Table Central & South America Dengue Vaccine Sales Market Share by Application (2016-2020)
Figure 2020 Central & South America Dengue Vaccine Market Share by Application
Figure Middle East and Africa Dengue Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Middle East and Africa Dengue Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Middle East and Africa Dengue Vaccine Sales by Country (2016-2020) (K Doses)
Table Middle East and Africa Dengue Vaccine Sales Market Share by Country (2016-2020)
Figure 2020 Middle East and Africa Dengue Vaccine Sales Market Share by Country
Table Middle East and Africa Dengue Vaccine Revenue by Country (2016-2020) (Million US$)
Table Middle East and Africa Dengue Vaccine Revenue Market Share by Country (2016-2020)
Figure 2020 Middle East and Africa Dengue Vaccine Revenue Market Share by Country
Figure Turkey Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Turkey Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure GCC Countries Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure GCC Countries Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Egypt Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Egypt Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure South Africa Dengue Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure South Africa Dengue Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Middle East and Africa Dengue Vaccine Sales by Type (2016-2020) (K Doses)
Table Middle East and Africa Dengue Vaccine Sales Market Share by Type (2016-2020)
Figure 2020 Middle East and Africa Dengue Vaccine Market Share by Type
Table Middle East and Africa Dengue Vaccine Sales by Application (2016-2020) (K Doses)
Table Middle East and Africa Dengue Vaccine Sales Market Share by Application (2016-2020)
Figure 2020 Middle East and Africa Dengue Vaccine Market Share by Application
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table GlaxoSmithKline Recent Development
Table Merck Sharp & Dohme Company Details
Table Merck Sharp & Dohme Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table Merck Sharp & Dohme Recent Development
Table Sanofi Company Details
Table Sanofi Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table Sanofi Recent Development
Table Takeda Pharmaceuticals Company Details
Table Takeda Pharmaceuticals Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table Takeda Pharmaceuticals Recent Development
Table GeneOne Life Sciences Company Details
Table GeneOne Life Sciences Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table GeneOne Life Sciences Recent Development
Table Medigen Biologics Company Details
Table Medigen Biologics Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table Medigen Biologics Recent Development
Table Panacea Biotec Company Details
Table Panacea Biotec Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table Panacea Biotec Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table Sun Pharmaceutical Recent Development
Table U.S NIH Company Details
Table U.S NIH Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table U.S NIH Recent Development
Table Vabiotech Company Details
Table Vabiotech Dengue Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2020)
Table Vabiotech Recent Development
Table Global Dengue Vaccine Sales Forecast by Regions 2021-2027 (K Doses)
Table Global Dengue Vaccine Sales Market Share Forecast by Regions 2021-2027
Table Global Dengue Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table Global Dengue Vaccine Revenue Market Share Forecast by Regions 2021-2027
Table Global Dengue Vaccine Sales Forecast by Type 2021-2027 (K Doses)
Table Global Dengue Vaccine Sales Market Share Forecast by Type 2021-2027
Table Global Dengue Vaccine Revenue Forecast by Type 2021-2027 (Million US$)
Table Global Dengue Vaccine Revenue Market Share Forecast by Type 2021-2027
Table Global Dengue Vaccine Sales Forecast by Application 2021-2027 (K Doses)
Table Global Dengue Vaccine Sales Market Share Forecast by Application 2021-2027
Figure North America Dengue Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure North America Dengue Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Europe Dengue Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Europe Dengue Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Asia Pacific Dengue Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Asia Pacific Dengue Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Central & South America Dengue Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Central & South America Dengue Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Middle East and Africa Dengue Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Middle East and Africa Dengue Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2021-2027)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Dengue Vaccine Value Chain
Table Dengue Vaccine Customers List
Figure Channels of Distribution
Table Dengue Vaccine Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources